Terapia primaria en aplasia de médula ósea: trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora

Gálvez, Kenny Mauricio; Solano, María Helena; Ramírez, Carlos Alberto; Abello, Virginia; Pedraza, Enrique; Esguerra, Hermann; Rosales, Carmen; Villamizar, Licet; Reyes, Jesús Antonio.
Repert. med. cir ; 16(3): 143-150, 2007. tab, graf
Artículo en Español | LILACS, COLNAL - Colombia-Nacional | ID: lil-523238

Documentos relacionados

  1. ConSpaS: a contrastive learning framework for identifying spatial domains by integrating local and global similarities.
  2. Non-HLA genetic mismatches and BMT outcome.
  3. The importance of establishing genetic phase in clinical medicine.
  4. Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study".
  5. European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group.
  6. A reply to Hurley et al. regarding Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.
  7. Comparison of platelet antibody screen, crossmatching and HLA antibody testing in patients refractory to platelet transfusions.
  8. Essential histocompatibility for the renal clinician-Part 1.
  9. Not all mismatches are equal: importance of alloreactivity direction.
  10. HLA-B leads survival after HCT.